We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Regulatory News (OBD)

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.10
Bid: 8.10
Ask: 8.56
Change: -0.20 (-2.41%)
Spread: 0.46 (5.679%)
Open: 8.30
High: 8.30
Low: 8.10
Prev. Close: 8.30
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

29 Aug 2018 16:47

RNS Number : 1851Z
Oxford BioDynamics PLC
29 August 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Oxford Biodynamics plc

2138005Y1TK258O5U928

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

 

A decrease in percentage ownership of the issuer's shares as a result of an increase in the issuer's issued share capital

X

3. Details of person subject to the notification obligationiv

Name

Philippa Hoyer Millar

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

28 August 2018

6. Date on which issuer notified (DD/MM/YYYY):

29 August 2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

4,473,140

-

4.85%

92,201,306

Position of previous notification (if

applicable)

4,473,140

-

5.2%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BD5H8572

4,473,140

-

4.85%

-

SUBTOTAL 8. A

4,473,140

4.85%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

Oxford, UK

Date of completion

28 August 2018

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLEASPNALKPEFF
Date   Source Headline
23rd Jan 20207:00 amRNSPublication of Annual Report and Notice of AGM
15th Jan 20202:15 pmRNSEpiSwitch used in diagnosis of canine lymphoma
20th Dec 20197:00 amRNSOBD enters into master service agreement
11th Dec 201911:00 amRNSPDMR Shareholding
10th Dec 20197:00 amRNSPrelim Results for year ended 30 September 2019
19th Nov 20197:00 amRNSNotice of Results
8th Nov 20197:02 amRNSOBD's EpiSwitch featured in presentations
30th Oct 20197:00 amRNSOBD appoints Iain McInnes to Advisory Board
25th Oct 20197:00 amRNSFirst patient enrolled in ALS biomarker study
12th Sep 201912:43 pmRNSPDMR Dealing
10th Sep 201910:26 amRNSPDMR Dealing
9th Sep 201912:48 pmRNSPDMR Dealing
6th Sep 201910:59 amRNSPDMR Dealing
3rd Sep 20199:47 amRNSPDMR Dealing
2nd Sep 201911:18 amRNSPDMR Dealing
29th Aug 20193:30 pmRNSPDMR Dealing
28th Aug 201910:11 amRNSPDMR Dealing
15th Aug 201910:59 amRNSPDMR Dealing
14th Aug 20191:15 pmRNSPDMR Dealing
5th Aug 201911:19 amRNSPDMR Dealing
1st Aug 20199:51 amRNSPDMR Dealing
26th Jul 201911:57 amRNSPDMR Shareholding
19th Jul 20197:00 amRNSOBD to present at MAC10
9th Jul 20197:00 amRNSDirector/PDMR Shareholding
13th Jun 20197:00 amRNSOBD appoints Dr Bartu Ahiska
12th Jun 20197:00 amRNSPDMR Dealing / Grant of Share Options
6th Jun 20193:14 pmRNSDirector/PDMR Shareholding
31st May 20197:00 amRNSBoard Transition
28th May 20197:00 amRNSInterim Results for 6 months ended 31 March 2019
8th May 20197:00 amRNSOBD to present at China BIO Conference
3rd May 20192:00 pmRNSOBD joins ALS Biomarker study sponsored by MTPA
29th Apr 20197:50 amRNSNotice of Interim Results
23rd Apr 20197:00 amRNSQueen's Award for Enterprise
5th Apr 20199:30 amRNSBoard Appointments
2nd Apr 20197:00 amRNSOBD US subsidiary and commercial lead
19th Mar 20197:00 amRNSOBD joins Imperial in a prostate cancer trial
14th Mar 20192:13 pmRNSResults of Annual General Meeting
15th Feb 201910:01 amRNSDirector/PDMR Shareholding
25th Jan 20197:00 amRNSPublication of Annual Report and Notice of AGM
11th Jan 20197:00 amRNSBoard Transition
11th Dec 20187:00 amRNSFinal Results
3rd Dec 201810:10 amRNSTotal Voting Rights
23rd Nov 20187:00 amRNSNotice of results for year ended 30 Sept 2018
12th Nov 20187:00 amRNSCollaboration into identifying diagnosis of Autism
8th Nov 20187:00 amRNSOBD signs fifth collaboration agreement
7th Nov 20187:00 amRNSStudy published in Faculty of 1000 Research
6th Nov 20187:00 amRNSIssue of Equity
1st Nov 20185:17 pmRNSTotal Voting Rights
2nd Oct 20187:00 amRNSIssue of Equity
26th Sep 20187:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.